RE:RE:I'm going to guess ...longrun86 wrote: Your post gave me a good laugh.
I am relatively new to this board but it certainly has some interesting characters.
I was hoping that this board would have more posts that would help me understand the business (ie: industry, target markets, ROW strategy, competitors, drug distribution strategies, etc.).
Sincerely,
LR
=======
Hey Longrun.
I'm sure we'll eventually have lots to talk about.
I recently spoke with management and I will update you on relevant items as we go.
LATAM is the focus and we have lots to optimize there - unfortunately COVID through a wrench into those plans and things can't be done as quickly as they'd like.
The focus will likely remain on LATAM for growth and this quiet period seems to indicate they are working on snagging bigger deals.
Unfortunately ... don't know what happens next.
If you haven't seen the 2014 video, I recomment you watch it and pay close attention to the graph at the end of the video. It tells you what you need to know. Actually, Goodman does a good job telling you the way it is - no sugar coatings.
It took Goodman 12 years the first time to get his share price really moving. It also took him 15 years to start the ROW program.
This time - ROW started 5+ years in. In a way, ROW started on day one with Knight, if you look at some of the licenses that were acquired for ROW countries.
Hope this helps.
https://www.canadianvaluestocks.com/jonathan-goodman/